Does LETROZOLE\RIBOCICLIB Cause Malignant neoplasm progression? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Malignant neoplasm progression have been filed in association with LETROZOLE\RIBOCICLIB. This represents 1.8% of all adverse event reports for LETROZOLE\RIBOCICLIB.
11
Reports of Malignant neoplasm progression with LETROZOLE\RIBOCICLIB
1.8%
of all LETROZOLE\RIBOCICLIB reports
2
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From LETROZOLE\RIBOCICLIB?
Of the 11 reports, 2 (18.2%) resulted in death, 2 (18.2%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LETROZOLE\RIBOCICLIB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does LETROZOLE\RIBOCICLIB Cause?
Fatigue (69)
Death (66)
Nausea (57)
White blood cell count decreased (39)
Diarrhoea (35)
Rash (27)
Alopecia (25)
Neoplasm malignant (25)
Malaise (24)
Cough (22)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which LETROZOLE\RIBOCICLIB Alternatives Have Lower Malignant neoplasm progression Risk?
LETROZOLE\RIBOCICLIB vs LEUCOVORIN
LETROZOLE\RIBOCICLIB vs LEUCOVORIN\LEUCOVORIN
LETROZOLE\RIBOCICLIB vs LEUPROLIDE
LETROZOLE\RIBOCICLIB vs LEVALBUTEROL
LETROZOLE\RIBOCICLIB vs LEVAMISOLE